TL;DR
Staphylococcus epidermidis is the most abundant bacterium on healthy human skin. On intact skin it is not a pathogen. It crowds out Staphylococcus aureus, secretes peptides that limit pathogen growth, and quietly teaches the immune system how to behave. Most of the panic about staph on the face comes from confusing it with its troublesome cousin. The two are not the same organism.
The first time a clinician asked me why I was so calm about a staph swab on my cheek, I realized how thoroughly the word staph had been pre-loaded with dread. It is one of those microbiology terms that doctors use carefully and the internet uses badly. Staphylococcus aureus, the dangerous one, gets the headlines. Staphylococcus epidermidis, the abundant one on healthy faces, gets none of them. The result is a generation of skincare buyers who assume any staph on the skin is the enemy.
It is not. Most days, S. epidermidis is the reason the enemy never moves in.
What S. epidermidis actually does on skin
S. epidermidis is a coagulase-negative staph that lives on roughly every healthy adult’s skin, particularly in moist zones (nostrils, armpits, groin, behind the ears). On the face it sits at lower density but it is still one of the dominant cultivable organisms in standard microbiome sequencing. The literature has tracked it as a commensal for decades.
Two functions stand out in the research. The first is competitive exclusion. S. epidermidis secretes a peptide called Esp that interferes with S. aureus biofilm formation. A 2010 paper in Nature by Iwase and colleagues showed that nasal carriers of Esp-producing S. epidermidis strains were significantly less likely to be colonized by S. aureus. The same logic appears to extend, with weaker evidence, to facial skin.
The second function is immune education. The Belkaid lab at NIH has published extensively on how skin commensals, S. epidermidis included, teach resident T cells what to ignore and what to attack. Skin without normal commensal exposure (in germ-free mouse models, and to a lesser extent in over-sanitized human skin) shows dysregulated immune responses. The bacterium is part of how the barrier learns to behave.
Where the confusion comes from
The medical literature does flag S. epidermidis in two specific clinical contexts: bloodstream infections from indwelling catheters, and prosthetic device infections. In both cases the organism is acting opportunistically, behind the skin barrier, in patients who are already compromised. Inside the body it is a problem. On the body, on intact skin, it is not.
Beauty content has flattened this distinction. A casual reader googling staph on the face encounters case reports of bacteremia and assumes the worst. The worst is rare and clinically distinct. On a face that does not have an open wound, S. epidermidis is the resident, not the intruder.
The contrarian H2: stop trying to sterilize your face
I see the same pattern in routines I audit for friends. A cleanser with benzalkonium chloride or triclosan-adjacent claims. A toner with high-percentage alcohol. A facial mist marketed as antibacterial. A nightly wipe that is, functionally, a hand sanitizer for the cheekbones.
The cumulative effect of all this antimicrobial pressure is not the targeted removal of S. aureus or C. acnes. It is broad-spectrum suppression of the resident microbiome, S. epidermidis included. What grows back first after a strong sanitizer is the fastest colonizer, which is often less benign than the slower commensal you just wiped out.
The data here is unsettled but consistent in direction. Sequencing studies on heavily routine-treated facial skin show reduced microbial diversity compared with low-routine controls. Reduced diversity is the marker most consistently associated with eczema, rosacea, and reactive sensitivity. The marketing promise of a clean face is, biologically, the wrong target.
The real numbers
The Human Microbiome Project, funded by the NIH and published in Nature in 2012, sequenced the bacterial communities of multiple body sites across 242 healthy adults. On facial skin, coagulase-negative staphylococci (S. epidermidis being the dominant species in that group) made up between 10 and 35 percent of the cultivable community depending on the site, with the higher percentages on the forehead and the lower on the cheeks. Cutibacterium acnes was higher in oily zones; Corynebacterium species filled most of the remainder.
A separate 2018 review in the Journal of Investigative Dermatology by Byrd, Belkaid, and Segre put the consensus position cleanly: S. epidermidis on intact skin is a commensal whose presence correlates with normal barrier function. Pathology in this organism is a setting problem, not an organism problem.
What this means for your routine
Three practical implications, none of which require a new product.
Stop using antibacterial face washes unless a clinician has specifically prescribed one. The benefit on intact skin is small; the cost to microbial diversity is real. Standard syndet cleansers with a neutral to slightly acidic pH do the cleaning without the broad-spectrum suppression.
Be cautious with high-percentage alcohol toners. The astringent feel is satisfying; the microbiome cost is invisible. If your skin tolerates alcohol-free chemistry (most do), use it.
Consider postbiotic-forward formulations rather than antimicrobial ones. Our own Microbiome Glow Serum sits in this category, designed to support the resident community rather than suppress it. For the broader thinking on how this fits into a slow routine, see the microbiome skincare explainer, the postbiotic vs probiotic primer, and the barrier repair routine guide.
FAQ
Is S. epidermidis ever a problem on the face? Rarely. On compromised skin (open wounds, post-surgery, immune compromise) it can become opportunistic. On healthy adult facial skin it is part of the normal community.
How is S. epidermidis different from S. aureus? S. aureus is coagulase-positive, produces a broader range of virulence factors, and is the species behind boils, impetigo, and the more aggressive skin infections. S. epidermidis is coagulase-negative and commensal on intact skin.
Can I increase my S. epidermidis levels with a probiotic product? Probably not directly. Topical live-bacteria products are a separate research area and not the same as cultivating your own resident community. The more reliable approach is to stop suppressing it with over-cleansing.
Does S. epidermidis cause acne? Not as a primary driver. C. acnes is more relevant to acne biology, and even there the strain-level picture is complicated. S. epidermidis on acne-prone skin is largely doing its commensal work.
Should I be worried if my dermatologist swabs and finds S. epidermidis? No, unless the clinical context is a wound or device infection. On routine facial swabs it is an expected resident.
Tag hub: More on the skin microbiome and what to do about it
Sources
Iwase T et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation. Nature 2010. Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nature Reviews Microbiology 2018. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012.